While overall customers are more satisfied with their experience shopping online for auto insurance, they are less thrilled with the websites of individual insurance companies, with only slightly more half saying they “definitely will” return to the site for their servicing needs, according to the latest J.D. Power study.
Imagine a powerful new treatment that could cut all cancer deaths by more than half.
In the age of $10,000-a-month cancer drugs that often extend life by the thinnest margins — a few precious months before the cancer rages back — the idea of such a potent effect sounds like a fantasy.
(HealthDay News) -- A new drug to treat bladder cancer was approved by the U.S. Food and Drug Administration on Wednesday.
Tecentriq (atezolizumab) treats the most common type of bladder cancer, called urothelial carcinoma. It's the first in its class of drugs, called PD-1/PD-L1 inhibitors, approved to treat this type of cancer.
Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., May 16, 2016.(Reuters) - Wall Street reversed course to trade slightly higher on Wednesday as the prospect of higher interest rates sent financial stocks up, offsetting a fall in retail shares.
It's fair to say that relations between the U.S. and China are strained, especially in regards to technology. Security researchers have often traced cyberattacks big and small back to China, for which the Chinese government often denies,
